Skip to main content
. 2020 Aug 14;2020:2164685. doi: 10.1155/2020/2164685

Figure 1.

Figure 1

The study route. NR: nonreactive, R: reactive, Pos: positive, Neg: negative, WB: Western blot, CLIA: Abbott ARCHITECT HIV Ag/Ab Combo, ECLIA: Roche Elecsys HIV combi PT, and NAT: nucleic acid testing of Cobas TaqScreen MPX test v2.0.